Balchem (BCPC) Financials

$164.10 +3.37 (+2.10%)

As of 04:00 PM Eastern

Annual Income Statements for Balchem

This table shows Balchem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	60	56	90	79	80	85	96	105	109	128
Consolidated Net Income / (Loss)	60	56	90	79	80	85	96	105	109	128
Net Income / (Loss) Continuing Operations	60	56	90	79	80	85	96	105	109	128
Total Pre-Tax Income	87	83	88	99	96	106	125	134	137	166
Total Operating Income	94	91	97	107	103	111	128	145	159	183
Total Gross Profit	168	181	189	204	211	224	243	280	302	336
Total Revenue	552	553	595	644	644	704	799	942	922	954
Operating Revenue	552	553	595	644	644	704	799	942	922	954
Total Cost of Revenue	384	372	406	439	432	480	556	662	620	617
Operating Cost of Revenue	384	372	406	439	432	480	556	662	620	617
Total Operating Expenses	74	90	92	97	109	113	116	135	143	153
Selling, General & Admin Expense	68	83	83	86	97	102	102	123	128	137
Research & Development Expense	5.99	7.33	9.31	12	11	10	14	12	15	17
Total Other Income / (Expense), net	-6.89	-7.90	-8.42	-8.07	-6.08	-4.73	-2.27	-11	-22	-16
Interest & Investment Income	0.01	-	-	-	-	-	-	-10	-23	-17
Other Income / (Expense), net	-0.31	-0.65	-0.88	-0.46	-0.12	-0.29	0.19	-1.17	0.68	0.07
Income Tax Expense	27	27	-1.58	20	17	22	29	28	29	38
Basic Earnings per Share	$1.92	$1.78	$2.83	$2.45	$2.48	$2.63	$2.98	$3.29	$3.38	$3.97
Weighted Average Basic Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Diluted Earnings per Share	$1.89	$1.75	$2.79	$2.42	$2.45	$2.60	$2.94	$3.25	$3.35	$3.93
Weighted Average Diluted Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Weighted Average Basic & Diluted Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Cash Dividends to Common per Share	-	-	-	-	-	-	-	$0.71	$0.79	$0.87

This table shows Balchem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	25	21	23	30	29	27	29	32	34	34
Consolidated Net Income / (Loss)	25	21	23	30	29	27	29	32	34	34
Net Income / (Loss) Continuing Operations	25	21	23	30	29	27	29	32	34	34
Total Pre-Tax Income	31	26	29	38	36	33	37	41	44	44
Total Operating Income	34	33	34	43	44	38	42	46	48	47
Total Gross Profit	68	69	73	77	77	75	82	83	85	86
Total Revenue	244	233	233	231	230	229	240	234	240	240
Operating Revenue	244	233	233	231	230	229	240	234	240	240
Total Cost of Revenue	176	164	159	154	153	154	158	151	155	154
Operating Cost of Revenue	176	164	159	154	153	154	158	151	155	154
Total Operating Expenses	35	35	39	35	33	37	40	37	37	39
Selling, General & Admin Expense	32	32	35	31	29	33	36	33	33	34
Research & Development Expense	3.00	3.04	3.45	3.80	3.87	3.94	4.10	3.85	4.33	4.51
Total Other Income / (Expense), net	-2.54	-7.69	-5.29	-4.44	-7.14	-5.07	-4.83	-4.57	-4.10	-2.96
Other Income / (Expense), net	1.10	-	0.28	0.73	-0.55	0.22	0.57	-0.33	-0.03	-0.14
Income Tax Expense	5.84	4.37	6.41	8.29	7.40	6.62	7.86	9.16	10	11
Basic Earnings per Share	$0.79	$0.67	$0.71	$0.94	$0.91	$0.82	$0.90	$0.99	$1.05	$1.03
Weighted Average Basic Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M
Diluted Earnings per Share	$0.78	$0.66	$0.70	$0.93	$0.90	$0.82	$0.89	$0.98	$1.03	$1.03
Weighted Average Diluted Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M
Weighted Average Basic & Diluted Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	35	-46	1.77	14	11	19	19	-37	-2.11	-15
Net Cash From Operating Activities	104	108	111	119	124	150	161	139	184	182
Net Cash From Continuing Operating Activities	104	108	111	119	124	150	161	139	184	182
Net Income / (Loss) Continuing Operations	60	56	90	79	80	85	96	105	109	128
Consolidated Net Income / (Loss)	60	56	90	79	80	85	96	105	109	128
Depreciation Expense	40	46	44	45	46	51	49	52	55	48
Non-Cash Adjustments To Reconcile Net Income	4.25	7.59	6.93	4.87	7.45	11	11	15	22	19
Changes in Operating Assets and Liabilities, net	-0.11	-2.15	-31	-9.41	-8.52	3.91	4.99	-34	-2.10	-13
Net Cash From Investing Activities	-42	-134	-43	-32	-156	-35	-35	-416	-35	-60
Net Cash From Continuing Investing Activities	-42	-134	-43	-32	-156	-35	-35	-416	-35	-60
Purchase of Property, Plant & Equipment	-41	-23	-28	-20	-28	-34	-37	-50	-38	-36
Acquisitions	-1.01	-112	-17	-17	-141	0.00	0.00	-366	-1.25	-24
Purchase of Investments	-	-	0.00	0.00	-1.00	-0.85	-0.09	-0.50	-0.29	-0.27
Sale of Property, Plant & Equipment	0.03	0.00	0.02	0.97	12	0.09	0.32	0.21	1.88	0.36
Sale and/or Maturity of Investments	0.00	-	-	-	-	-	0.00	0.00	2.74	0.00
Net Cash From Financing Activities	-26	-19	-69	-71	43	-101	-102	247	-153	-134
Net Cash From Continuing Financing Activities	-26	-19	-69	-71	43	-101	-102	247	-153	-134
Repayment of Debt	-35	-89	-89	-276	-94	-95	-60	-135	-149	-146
Repurchase of Common Equity	-1.21	-1.59	-1.91	-1.39	-21	-13	-35	-35	-4.47	-5.68
Payment of Dividends	-9.25	-11	-12	-13	-15	-17	-19	-21	-23	-26
Issuance of Debt	-	73	25	211	169	10	5.00	435	18	26
Other Financing Activities, net	20	9.74	9.73	8.27	4.84	14	6.78	3.04	5.02	17
Effect of Exchange Rate Changes	-1.20	-0.72	2.48	-1.41	-0.22	4.16	-4.37	-5.88	2.26	-3.38

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-20	10	-6.36	6.66	10	-13	-4.10	3.39	9.96	-24
Net Cash From Operating Activities	42	42	35	35	47	67	33	45	51	52
Net Cash From Continuing Operating Activities	42	42	35	35	47	67	33	45	51	52
Net Income / (Loss) Continuing Operations	25	21	23	30	29	27	29	32	34	34
Consolidated Net Income / (Loss)	25	21	23	30	29	27	29	32	34	34
Depreciation Expense	14	14	14	13	14	14	14	13	11	11
Non-Cash Adjustments To Reconcile Net Income	1.55	5.67	3.48	9.36	5.50	4.04	4.10	4.63	5.04	4.76
Changes in Operating Assets and Liabilities, net	0.72	0.69	-5.00	-18	-1.86	23	-13	-4.22	1.53	3.07
Net Cash From Investing Activities	-85	-14	-10	-3.61	-9.28	-12	-6.74	-6.86	-9.18	-37
Net Cash From Continuing Investing Activities	-85	-14	-10	-3.61	-9.28	-12	-6.74	-6.86	-9.18	-37
Purchase of Property, Plant & Equipment	-15	-14	-9.66	-8.22	-8.30	-12	-6.91	-6.88	-9.15	-13
Acquisitions	-70	-	-0.34	-	-0.91	-	0.00	-	-	-24
Purchase of Investments	-	-0.35	-0.06	-0.02	-0.07	-0.15	-0.04	-0.04	-0.03	-0.16
Net Cash From Financing Activities	28	-21	-33	-25	-25	-70	-30	-34	-34	-35
Net Cash From Continuing Financing Activities	28	-21	-33	-25	-25	-70	-30	-34	-34	-35
Repayment of Debt	-42	-22	-22	-26	-30	-71	-34	-35	-40	-37
Repurchase of Common Equity	-0.05	-0.18	-3.85	-0.08	-0.10	-0.44	-5.20	-0.01	-0.16	-0.31
Payment of Dividends	-0.00	-0.01	-23	-0.00	-0.00	-	-26	-0.01	-0.00	-0.00
Other Financing Activities, net	0.80	0.99	2.40	1.32	0.01	1.30	8.73	0.84	5.34	2.10
Effect of Exchange Rate Changes	-4.59	4.31	2.18	0.04	-2.06	2.10	-0.72	-0.56	2.23	-4.32

This table presents Balchem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	880	949	964	981	1,156	1,166	1,199	1,625	1,597	1,575
Total Current Assets	198	188	199	226	255	267	322	336	314	314
Cash & Equivalents	85	39	40	54	66	85	103	67	64	50
Accounts Receivable	60	83	91	100	93	98	117	132	125	120
Inventories, net	46	57	61	67	84	71	91	120	110	131
Prepaid Expenses	3.21	4.11	4.77	3.83	4.39	6.60	6.12	4.90	7.80	8.05
Other Current Assets	2.91	4.48	2.22	1.48	2.45	3.44	4.41	13	7.19	5.74
Plant, Property, & Equipment, net	159	166	190	191	217	228	238	271	276	282
Total Noncurrent Assets	523	594	575	564	684	671	640	1,017	1,007	979
Noncurrent Note & Lease Receivables	-	-	-	-	-	2.57	2.36	2.34	2.10	1.73
Goodwill	384	440	441	448	524	529	524	770	779	780
Intangible Assets	135	147	128	109	144	122	95	213	191	165
Other Noncurrent Operating Assets	4.06	7.14	5.07	6.72	16	17	19	32	35	33
Total Liabilities & Shareholders' Equity	880	949	964	981	1,156	1,166	1,199	1,625	1,597	1,575
Total Liabilities	416	428	347	290	412	338	322	686	543	425
Total Current Liabilities	81	101	108	82	92	94	144	140	148	158
Accounts Payable	15	33	28	33	37	24	56	57	56	55
Accrued Expenses	13	15	23	22	25	30	43	37	41	44
Dividends Payable	11	12	13	15	17	19	21	23	26	29
Current Deferred & Payable Income Tax Liabilities	2.73	-	-	0.44	-	0.00	1.33	2.28	4.97	4.47
Current Employee Benefit Liabilities	5.13	6.65	8.53	11	11	20	20	17	17	23
Other Current Liabilities	-	-	-	-	2.48	2.34	2.36	4.02	4.22	3.33
Total Noncurrent Liabilities	335	327	238	208	320	243	179	546	395	268
Long-Term Debt	268	252	190	163	256	174	109	467	326	209
Capital Lease Obligations	-	-	-	0.00	-	2.47	2.30	2.21	1.94	1.75
Noncurrent Deferred & Payable Income Tax Liabilities	67	74	49	44	56	51	46	63	52	44
Other Noncurrent Operating Liabilities	-	-	-	0.00	6.93	15	21	14	15	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	464	521	617	692	744	828	877	938	1,054	1,150
Total Preferred & Common Equity	464	521	617	692	744	828	877	938	1,054	1,150
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	464	521	617	692	744	828	877	938	1,054	1,150
Common Stock	125	140	154	167	176	167	150	131	148	176
Retained Earnings	344	388	465	528	591	657	732	814	897	997
Accumulated Other Comprehensive Income / (Loss)	-5.11	-6.85	-1.64	-3.60	-5.56	4.17	-4.99	-7.15	8.69	-24

This table presents Balchem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,633	1,629	1,619	1,603	1,589	1,575	1,597
Total Current Assets	368	336	337	341	325	320	326
Cash & Equivalents	56	60	67	77	60	64	74
Accounts Receivable	141	131	125	129	140	123	121
Inventories, net	139	125	125	116	110	117	119
Prepaid Expenses	6.94	7.43	8.83	7.24	7.12	9.96	7.83
Other Current Assets	20	12	7.24	6.59	7.13	5.96	5.42
Plant, Property, & Equipment, net	260	276	271	269	274	273	277
Total Noncurrent Assets	1,005	1,017	1,011	993	990	982	994
Noncurrent Note & Lease Receivables	2.20	2.28	2.22	2.16	2.04	1.98	1.78
Goodwill	749	774	774	767	772	770	781
Intangible Assets	227	209	203	192	182	176	178
Other Noncurrent Operating Assets	26	31	32	33	34	34	33
Total Liabilities & Shareholders' Equity	1,633	1,629	1,619	1,603	1,589	1,575	1,597
Total Liabilities	737	655	612	578	510	463	420
Total Current Liabilities	142	117	114	108	124	113	109
Accounts Payable	73	53	56	50	60	55	46
Accrued Expenses	50	43	41	43	38	37	40
Dividends Payable	0.13	0.19	0.19	0.18	0.07	0.05	0.05
Current Deferred & Payable Income Tax Liabilities	0.00	7.88	0.00	0.00	12	3.44	1.96
Current Employee Benefit Liabilities	15	9.22	13	12	11	15	18
Other Current Liabilities	3.90	3.06	4.09	3.86	4.05	3.84	3.40
Total Noncurrent Liabilities	595	539	498	470	385	349	310
Long-Term Debt	477	461	421	396	319	284	245
Capital Lease Obligations	2.17	2.16	2.10	2.00	1.90	1.85	1.80
Noncurrent Deferred & Payable Income Tax Liabilities	77	63	62	59	51	50	50
Other Noncurrent Operating Liabilities	39	13	13	13	14	14	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	896	973	1,007	1,025	1,079	1,112	1,177
Total Preferred & Common Equity	896	973	1,007	1,025	1,079	1,112	1,177
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	896	973	1,007	1,025	1,079	1,112	1,177
Common Stock	127	134	139	143	156	161	170
Retained Earnings	816	837	867	896	926	959	992
Accumulated Other Comprehensive Income / (Loss)	-47	1.86	0.19	-14	-3.87	-7.13	15

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.05%	0.13%	7.52%	8.22%	0.00%	9.31%	13.56%	17.94%	-2.11%	3.39%
EBITDA Growth	18.60%	2.08%	2.94%	7.77%	-1.99%	9.33%	8.90%	10.93%	9.67%	7.52%
EBIT Growth	14.02%	-3.69%	6.46%	11.06%	-3.94%	8.22%	15.18%	12.79%	11.01%	14.45%
NOPAT Growth	14.44%	-4.88%	60.89%	-13.85%	-0.34%	4.37%	10.70%	16.90%	10.06%	12.15%
Net Income Growth	13.05%	-6.28%	60.92%	-12.77%	1.40%	6.22%	13.57%	9.64%	3.01%	18.36%
EPS Growth	11.83%	-7.41%	59.43%	-13.26%	1.24%	6.12%	13.08%	10.54%	3.08%	17.31%
Operating Cash Flow Growth	21.65%	3.65%	2.79%	7.30%	4.86%	20.92%	6.66%	-13.69%	32.64%	-0.96%
Free Cash Flow Firm Growth	112.33%	-145.99%	332.51%	27.46%	-160.41%	298.49%	30.86%	-362.06%	142.66%	-1.68%
Invested Capital Growth	0.43%	12.94%	4.21%	0.15%	16.58%	-1.27%	-3.58%	50.68%	-1.55%	-0.25%
Revenue Q/Q Growth	-5.14%	1.47%	3.21%	0.67%	0.47%	2.06%	4.23%	2.10%	-0.41%	1.20%
EBITDA Q/Q Growth	-3.62%	3.08%	0.88%	0.38%	-1.45%	3.75%	2.41%	-0.03%	2.81%	2.48%
EBIT Q/Q Growth	-4.91%	2.74%	1.95%	0.55%	-3.18%	5.02%	3.94%	-1.16%	3.70%	5.02%
NOPAT Q/Q Growth	-5.19%	0.46%	40.45%	-21.51%	-0.42%	1.52%	2.74%	1.72%	2.58%	3.75%
Net Income Q/Q Growth	-5.33%	0.48%	40.69%	-21.59%	0.06%	2.15%	2.99%	-3.25%	5.07%	5.71%
EPS Q/Q Growth	-5.03%	0.00%	40.20%	-21.94%	0.00%	2.36%	2.44%	-2.69%	5.02%	5.65%
Operating Cash Flow Q/Q Growth	-9.68%	2.69%	3.14%	7.57%	-5.00%	11.06%	-2.11%	-2.01%	16.30%	-7.66%
Free Cash Flow Firm Q/Q Growth	-21.32%	29.25%	-2.38%	15.64%	-635.29%	115.14%	11.53%	-20.73%	53.96%	9.34%
Invested Capital Q/Q Growth	0.57%	-0.95%	2.84%	-1.46%	5.27%	-0.51%	-1.72%	3.43%	-0.23%	-0.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.43%	32.69%	31.78%	31.73%	32.84%	31.82%	30.43%	29.76%	32.75%	35.25%
EBITDA Margin	24.18%	24.65%	23.60%	23.51%	23.04%	23.04%	22.10%	20.78%	23.29%	24.22%
Operating Margin	17.01%	16.42%	16.29%	16.64%	15.93%	15.80%	15.96%	15.41%	17.26%	19.18%
EBIT Margin	16.95%	16.30%	16.14%	16.57%	15.91%	15.75%	15.98%	15.28%	17.33%	19.19%
Profit (Net Income) Margin	10.81%	10.12%	15.14%	12.21%	12.38%	12.03%	12.03%	11.18%	11.77%	13.47%
Tax Burden Percent	68.60%	67.49%	101.79%	79.34%	82.58%	79.52%	76.74%	78.78%	79.08%	77.18%
Interest Burden Percent	92.97%	91.95%	92.16%	92.86%	94.18%	96.00%	98.08%	92.87%	85.86%	90.97%
Effective Tax Rate	31.40%	32.51%	-1.79%	20.66%	17.42%	20.48%	23.26%	21.22%	20.92%	22.82%
Return on Invested Capital (ROIC)	9.33%	8.32%	12.36%	10.42%	9.58%	9.35%	10.61%	10.08%	9.30%	10.52%
ROIC Less NNEP Spread (ROIC-NNEP)	7.53%	6.14%	8.62%	6.45%	6.56%	6.99%	8.11%	6.11%	4.45%	5.22%
Return on Net Nonoperating Assets (RNNOA)	4.63%	3.05%	3.48%	1.59%	1.52%	1.42%	0.66%	1.53%	1.60%	1.14%
Return on Equity (ROE)	13.96%	11.37%	15.83%	12.01%	11.10%	10.77%	11.27%	11.61%	10.90%	11.66%
Cash Return on Invested Capital (CROIC)	8.90%	-3.84%	8.23%	10.28%	-5.73%	10.63%	14.25%	-30.36%	10.86%	10.77%
Operating Return on Assets (OROA)	10.76%	9.87%	10.04%	10.97%	9.59%	9.55%	10.80%	10.20%	9.92%	11.54%
Return on Assets (ROA)	6.86%	6.12%	9.42%	8.08%	7.46%	7.29%	8.13%	7.46%	6.74%	8.10%
Return on Common Equity (ROCE)	13.96%	11.37%	15.83%	12.01%	11.10%	10.77%	11.27%	11.61%	10.90%	11.66%
Return on Equity Simple (ROE_SIMPLE)	12.88%	10.74%	14.60%	11.36%	10.71%	10.22%	10.96%	11.23%	10.30%	11.17%
Net Operating Profit after Tax (NOPAT)	64	61	99	85	85	88	98	114	126	141
NOPAT Margin	11.67%	11.08%	16.58%	13.20%	13.16%	12.56%	12.25%	12.14%	13.65%	14.80%
Net Nonoperating Expense Percent (NNEP)	1.80%	2.18%	3.73%	3.97%	3.02%	2.36%	2.50%	3.96%	4.85%	5.30%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.12%	9.11%	10.37%
Cost of Revenue to Revenue	69.57%	67.31%	68.22%	68.27%	67.16%	68.18%	69.57%	70.24%	67.25%	64.75%
SG&A Expenses to Revenue	12.34%	14.95%	13.92%	13.29%	15.14%	14.56%	12.78%	13.06%	13.86%	14.31%
R&D to Revenue	1.08%	1.32%	1.56%	1.80%	1.77%	1.47%	1.69%	1.29%	1.63%	1.76%
Operating Expenses to Revenue	13.42%	16.27%	15.49%	15.09%	16.90%	16.02%	14.48%	14.35%	15.49%	16.07%
Earnings before Interest and Taxes (EBIT)	94	90	96	107	102	111	128	144	160	183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	134	136	140	151	148	162	177	196	215	231
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.97	4.92	4.05	3.56	4.31	4.43	6.16	4.14	4.53	4.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	52.68	18.35	42.30	20.73	20.89	0.00	56.89	25.87
Price to Revenue (P/Rev)	3.33	4.64	4.20	3.83	4.98	5.22	6.76	4.12	5.17	5.56
Price to Earnings (P/E)	30.79	45.84	27.75	31.35	40.21	43.39	56.17	36.85	43.95	41.24
Dividend Yield	0.58%	0.47%	0.54%	0.62%	0.52%	0.51%	0.38%	0.59%	0.53%	0.53%
Earnings Yield	3.25%	2.18%	3.60%	3.19%	2.49%	2.30%	1.78%	2.71%	2.28%	2.42%
Enterprise Value to Invested Capital (EV/IC)	2.97	3.60	3.29	3.15	3.57	4.01	5.97	3.14	3.75	4.07
Enterprise Value to Revenue (EV/Rev)	3.72	5.09	4.51	4.00	5.27	5.35	6.77	4.55	5.46	5.73
Enterprise Value to EBITDA (EV/EBITDA)	15.39	20.64	19.12	17.00	22.89	23.21	30.62	21.88	23.44	23.64
Enterprise Value to EBIT (EV/EBIT)	21.96	31.21	27.95	24.12	33.14	33.95	42.34	29.76	31.49	29.84
Enterprise Value to NOPAT (EV/NOPAT)	31.91	45.91	27.21	30.27	40.08	42.58	55.25	37.47	39.99	38.68
Enterprise Value to Operating Cash Flow (EV/OCF)	19.81	26.16	24.26	21.67	27.27	25.01	33.68	30.94	27.40	30.00
Enterprise Value to Free Cash Flow (EV/FCFF)	33.45	0.00	40.82	30.70	0.00	37.46	41.12	0.00	34.25	37.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.55	0.36	0.24	0.34	0.21	0.13	0.50	0.31	0.18
Long-Term Debt to Equity	0.58	0.48	0.31	0.24	0.34	0.21	0.13	0.50	0.31	0.18
Financial Leverage	0.61	0.50	0.40	0.25	0.23	0.20	0.08	0.25	0.36	0.22
Leverage Ratio	2.04	1.86	1.68	1.49	1.49	1.48	1.39	1.56	1.62	1.44
Compound Leverage Factor	1.89	1.71	1.55	1.38	1.40	1.42	1.36	1.44	1.39	1.31
Debt to Total Capital	39.49%	35.55%	26.71%	19.11%	25.64%	17.57%	11.22%	33.35%	23.74%	15.51%
Short-Term Debt to Total Capital	4.57%	4.33%	4.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.92%	31.22%	22.55%	19.11%	25.64%	17.57%	11.22%	33.35%	23.74%	15.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.51%	64.45%	73.29%	80.89%	74.36%	82.43%	88.78%	66.65%	76.26%	84.49%
Debt to EBITDA	2.27	2.11	1.60	1.08	1.73	1.09	0.63	2.40	1.53	0.91
Net Debt to EBITDA	1.63	1.82	1.31	0.72	1.29	0.57	0.04	2.06	1.23	0.70
Long-Term Debt to EBITDA	2.00	1.85	1.35	1.08	1.73	1.09	0.63	2.40	1.53	0.91
Debt to NOPAT	4.70	4.69	2.28	1.92	3.03	2.00	1.13	4.11	2.61	1.50
Net Debt to NOPAT	3.38	4.06	1.87	1.28	2.25	1.04	0.08	3.52	2.09	1.14
Long-Term Debt to NOPAT	4.15	4.12	1.92	1.92	3.03	2.00	1.13	4.11	2.61	1.50
Altman Z-Score	4.34	5.18	6.06	7.05	6.40	8.41	12.10	5.11	7.09	9.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.44	1.87	1.84	2.76	2.76	2.83	2.24	2.40	2.12	1.99
Quick Ratio	1.79	1.21	1.21	1.87	1.72	1.94	1.53	1.41	1.28	1.07
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	61	-28	66	84	-51	100	131	-345	147	145
Operating Cash Flow to CapEx	251.60%	467.27%	393.73%	632.81%	736.89%	446.03%	433.29%	278.53%	510.29%	515.55%
Free Cash Flow to Firm to Interest Expense	9.32	-3.90	8.73	11.01	-8.49	22.63	53.53	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	15.75	14.83	14.69	15.60	20.89	33.90	65.36	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	9.49	11.66	10.96	13.13	18.05	26.30	50.27	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.61	0.62	0.66	0.60	0.61	0.68	0.67	0.57	0.60
Accounts Receivable Turnover	8.34	7.70	6.82	6.75	6.67	7.34	7.41	7.57	7.18	7.79
Inventory Turnover	8.03	7.21	6.88	6.87	5.72	6.21	6.88	6.28	5.41	5.14
Fixed Asset Turnover	3.81	3.41	3.35	3.38	3.16	3.16	3.43	3.70	3.37	3.42
Accounts Payable Turnover	19.68	15.77	13.31	14.22	12.25	15.73	13.90	11.66	11.00	11.20
Days Sales Outstanding (DSO)	43.76	47.42	53.54	54.09	54.72	49.71	49.25	48.22	50.82	46.87
Days Inventory Outstanding (DIO)	45.44	50.65	53.04	53.11	63.77	58.78	53.08	58.10	67.42	71.03
Days Payable Outstanding (DPO)	18.54	23.15	27.42	25.66	29.81	23.21	26.26	31.31	33.19	32.58
Cash Conversion Cycle (CCC)	70.65	74.92	79.16	81.54	88.68	85.28	76.07	75.01	85.05	85.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	692	782	815	816	951	939	906	1,364	1,343	1,340
Invested Capital Turnover	0.80	0.75	0.75	0.79	0.73	0.74	0.87	0.83	0.68	0.71
Increase / (Decrease) in Invested Capital	2.97	90	33	1.18	135	-12	-34	459	-21	-3.35
Enterprise Value (EV)	2,057	2,815	2,684	2,572	3,394	3,763	5,406	4,286	5,035	5,460
Market Capitalization	1,839	2,566	2,499	2,463	3,204	3,671	5,399	3,883	4,771	5,299
Book Value per Share	$14.71	$16.43	$19.28	$21.45	$23.12	$25.60	$27.08	$29.20	$32.69	$35.37
Tangible Book Value per Share	($1.75)	($2.09)	$1.48	$4.16	$2.35	$5.47	$7.98	($1.39)	$2.60	$6.30
Total Capital	766	808	842	855	1,000	1,005	988	1,408	1,382	1,361
Total Debt	303	287	225	163	256	177	111	470	328	211
Total Long-Term Debt	268	252	190	163	256	177	111	470	328	211
Net Debt	218	249	184	109	191	92	7.63	403	264	162
Capital Expenditures (CapEx)	41	23	28	19	17	34	37	50	36	35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	67	84	86	90	97	88	75	129	101	107
Debt-free Net Working Capital (DFNWC)	152	122	126	144	163	172	178	196	166	156
Net Working Capital (NWC)	117	87	91	144	163	172	178	196	166	156
Net Nonoperating Expense (NNE)	4.73	5.33	8.57	6.40	5.02	3.76	1.74	9.01	17	13
Net Nonoperating Obligations (NNO)	229	261	198	124	208	111	29	426	289	190
Total Depreciation and Amortization (D&A)	40	46	44	45	46	51	49	52	55	48
Debt-free, Cash-free Net Working Capital to Revenue	12.20%	15.15%	14.38%	13.98%	15.07%	12.49%	9.41%	13.71%	10.98%	11.17%
Debt-free Net Working Capital to Revenue	27.54%	22.13%	21.17%	22.41%	25.27%	24.51%	22.33%	20.77%	17.97%	16.37%
Net Working Capital to Revenue	21.21%	15.81%	15.29%	22.41%	25.27%	24.51%	22.33%	20.77%	17.97%	16.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.92	$1.78	$2.83	$2.45	$2.48	$2.63	$2.98	$3.29	$3.38	$3.97
Adjusted Weighted Average Basic Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Adjusted Diluted Earnings per Share	$1.89	$1.75	$2.79	$2.42	$2.45	$2.60	$2.94	$3.25	$3.35	$3.93
Adjusted Weighted Average Diluted Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M
Normalized Net Operating Profit after Tax (NOPAT)	64	61	68	85	85	88	98	114	126	141
Normalized NOPAT Margin	11.67%	11.08%	11.40%	13.20%	13.16%	12.56%	12.25%	12.14%	13.65%	14.80%
Pre Tax Income Margin	15.76%	14.99%	14.88%	15.39%	14.99%	15.12%	15.67%	14.19%	14.88%	17.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.20	12.43	12.75	14.01	17.19	24.97	51.99	0.00	0.00	0.00
NOPAT to Interest Expense	9.78	8.45	13.10	11.16	14.21	19.91	39.84	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	7.94	9.26	9.02	11.55	14.36	17.37	36.91	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	3.52	5.28	9.37	8.70	11.38	12.31	24.76	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.49%	19.15%	13.40%	17.09%	19.00%	19.74%	19.48%	19.66%	21.07%	19.91%
Augmented Payout Ratio	17.51%	21.99%	15.51%	18.87%	45.76%	35.65%	56.15%	53.28%	25.19%	24.33%

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.45%	9.10%	1.60%	-2.30%	-5.86%	-1.65%	3.06%	1.22%	4.35%	4.94%
EBITDA Growth	8.98%	2.66%	-3.85%	9.28%	16.49%	11.48%	15.70%	1.72%	3.51%	10.61%
EBIT Growth	6.39%	-1.21%	-9.53%	8.32%	24.02%	15.77%	21.81%	4.37%	11.37%	22.68%
NOPAT Growth	7.75%	8.65%	-8.95%	10.91%	27.29%	11.02%	22.16%	6.06%	6.42%	16.64%
Net Income Growth	0.94%	-14.20%	-21.50%	1.10%	15.15%	24.49%	27.64%	6.51%	16.38%	26.02%
EPS Growth	1.30%	-12.00%	-21.35%	1.09%	15.38%	24.24%	27.14%	5.38%	14.44%	25.61%
Operating Cash Flow Growth	5.01%	-6.37%	396.20%	-27.46%	11.79%	61.82%	-4.16%	28.58%	10.27%	-22.39%
Free Cash Flow Firm Growth	-872.12%	-829.90%	-18,473.56%	83.35%	102.03%	112.01%	117.72%	221.14%	340.29%	-24.40%
Invested Capital Growth	43.18%	50.68%	44.20%	6.80%	2.07%	-1.55%	-2.70%	-2.12%	0.29%	-0.25%
Revenue Q/Q Growth	3.20%	-4.80%	0.00%	-0.55%	-0.56%	-0.54%	4.79%	-2.33%	2.50%	0.03%
EBITDA Q/Q Growth	-6.38%	-3.34%	2.40%	17.92%	-0.21%	-7.49%	6.27%	3.68%	1.54%	-1.13%
EBIT Q/Q Growth	-13.65%	-4.09%	4.14%	25.60%	-1.13%	-10.47%	9.57%	7.62%	5.49%	-1.38%
NOPAT Q/Q Growth	-9.81%	1.27%	-2.98%	25.17%	3.51%	-11.67%	6.76%	8.67%	3.85%	-3.19%
Net Income Q/Q Growth	-15.22%	-15.22%	6.09%	32.58%	-3.44%	-8.35%	8.77%	10.64%	5.51%	-0.75%
EPS Q/Q Growth	-15.22%	-15.38%	6.06%	32.86%	-3.23%	-8.89%	8.54%	10.11%	5.10%	0.00%
Operating Cash Flow Q/Q Growth	-13.72%	0.08%	-16.37%	0.44%	32.97%	44.88%	-50.47%	34.76%	14.02%	1.98%
Free Cash Flow Firm Q/Q Growth	-15.83%	-16.39%	8.41%	86.51%	114.12%	589.14%	35.08%	-7.81%	-48.70%	18.32%
Invested Capital Q/Q Growth	3.35%	3.43%	0.86%	-0.94%	-1.23%	-0.23%	-0.32%	-0.35%	1.20%	-0.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.01%	29.52%	31.47%	33.45%	33.29%	32.79%	34.01%	35.46%	35.58%	35.97%
EBITDA Margin	19.99%	20.30%	20.78%	24.64%	24.73%	23.01%	23.33%	24.77%	24.53%	24.25%
Operating Margin	13.77%	14.32%	14.80%	18.52%	18.97%	16.76%	17.39%	19.56%	20.00%	19.77%
EBIT Margin	14.22%	14.32%	14.92%	18.84%	18.73%	16.86%	17.63%	19.42%	19.99%	19.71%
Profit (Net Income) Margin	10.34%	9.21%	9.77%	13.02%	12.64%	11.65%	12.09%	13.70%	14.10%	13.99%
Tax Burden Percent	81.23%	83.05%	77.99%	78.41%	79.71%	80.10%	78.66%	77.79%	77.09%	75.49%
Interest Burden Percent	89.51%	77.39%	83.96%	88.15%	84.69%	86.28%	87.22%	90.67%	91.51%	94.04%
Effective Tax Rate	18.77%	16.95%	22.01%	21.59%	20.29%	19.90%	21.34%	22.21%	22.91%	24.51%
Return on Invested Capital (ROIC)	9.21%	9.88%	9.37%	10.35%	10.51%	9.15%	9.37%	10.52%	10.78%	10.61%
ROIC Less NNEP Spread (ROIC-NNEP)	8.31%	7.13%	7.66%	9.40%	8.98%	8.01%	8.22%	9.29%	9.50%	9.68%
Return on Net Nonoperating Assets (RNNOA)	2.12%	1.78%	2.01%	3.60%	3.48%	2.88%	2.66%	2.54%	2.13%	2.10%
Return on Equity (ROE)	11.33%	11.66%	11.37%	13.95%	13.99%	12.03%	12.02%	13.06%	12.91%	12.71%
Cash Return on Invested Capital (CROIC)	-25.47%	-30.36%	-26.60%	2.16%	7.16%	10.86%	12.45%	12.07%	9.80%	10.77%
Operating Return on Assets (OROA)	9.33%	9.56%	9.99%	10.99%	10.72%	9.65%	10.19%	11.34%	11.77%	11.85%
Return on Assets (ROA)	6.78%	6.14%	6.54%	7.59%	7.24%	6.67%	6.99%	8.00%	8.30%	8.41%
Return on Common Equity (ROCE)	11.33%	11.66%	11.37%	13.95%	13.99%	12.03%	12.02%	13.06%	12.91%	12.71%
Return on Equity Simple (ROE_SIMPLE)	12.16%	0.00%	10.19%	9.88%	10.08%	0.00%	10.64%	10.50%	10.32%	0.00%
Net Operating Profit after Tax (NOPAT)	27	28	27	34	35	31	33	36	37	36
NOPAT Margin	11.18%	11.89%	11.54%	14.52%	15.12%	13.43%	13.68%	15.22%	15.42%	14.92%
Net Nonoperating Expense Percent (NNEP)	0.91%	2.75%	1.71%	0.95%	1.53%	1.13%	1.15%	1.23%	1.28%	0.93%
Return On Investment Capital (ROIC_SIMPLE)	-	1.96%	-	-	-	2.22%	-	-	-	2.63%
Cost of Revenue to Revenue	71.99%	70.48%	68.53%	66.55%	66.71%	67.21%	65.99%	64.54%	64.42%	64.03%
SG&A Expenses to Revenue	13.02%	13.89%	15.19%	13.28%	12.64%	14.31%	14.91%	14.24%	13.77%	14.33%
R&D to Revenue	1.23%	1.31%	1.48%	1.64%	1.68%	1.72%	1.71%	1.65%	1.80%	1.88%
Operating Expenses to Revenue	14.25%	15.20%	16.67%	14.92%	14.32%	16.03%	16.62%	15.89%	15.57%	16.21%
Earnings before Interest and Taxes (EBIT)	35	33	35	44	43	39	42	45	48	47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	49	47	48	57	57	53	56	58	59	58
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.31	4.14	4.16	4.29	3.88	4.53	4.63	4.49	4.85	4.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	144.01	59.76	56.89	39.90	30.03	26.12	25.87
Price to Revenue (P/Rev)	4.18	4.12	4.28	4.59	4.29	5.17	5.37	5.35	6.06	5.56
Price to Earnings (P/E)	35.46	36.85	40.82	43.44	38.50	43.95	43.51	42.74	46.98	41.24
Dividend Yield	0.53%	0.59%	0.56%	0.53%	0.58%	0.53%	0.51%	0.51%	0.45%	0.53%
Earnings Yield	2.82%	2.71%	2.45%	2.30%	2.60%	2.28%	2.30%	2.34%	2.13%	2.42%
Enterprise Value to Invested Capital (EV/IC)	3.25	3.14	3.23	3.43	3.19	3.75	3.93	3.91	4.36	4.07
Enterprise Value to Revenue (EV/Rev)	4.64	4.55	4.70	4.97	4.64	5.46	5.65	5.59	6.24	5.73
Enterprise Value to EBITDA (EV/EBITDA)	21.87	21.88	22.84	23.48	20.57	23.44	23.63	23.34	26.10	23.64
Enterprise Value to EBIT (EV/EBIT)	29.41	29.76	31.50	32.44	27.88	31.49	31.39	30.79	33.77	29.84
Enterprise Value to NOPAT (EV/NOPAT)	38.10	37.47	39.79	40.57	35.03	39.99	39.87	38.95	43.23	38.68
Enterprise Value to Operating Cash Flow (EV/OCF)	30.31	30.94	26.75	30.55	27.20	27.40	28.83	27.11	29.85	30.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	164.40	45.02	34.25	31.10	32.03	44.51	37.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.54	0.50	0.48	0.42	0.39	0.31	0.30	0.26	0.21	0.18
Long-Term Debt to Equity	0.54	0.50	0.48	0.42	0.39	0.31	0.30	0.26	0.21	0.18
Financial Leverage	0.26	0.25	0.26	0.38	0.39	0.36	0.32	0.27	0.22	0.22
Leverage Ratio	1.58	1.56	1.53	1.69	1.68	1.62	1.57	1.51	1.45	1.44
Compound Leverage Factor	1.41	1.20	1.28	1.49	1.43	1.40	1.37	1.37	1.33	1.35
Debt to Total Capital	34.87%	33.35%	32.22%	29.58%	27.96%	23.74%	22.90%	20.43%	17.33%	15.51%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.87%	33.35%	32.22%	29.58%	27.96%	23.74%	22.90%	20.43%	17.33%	15.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.13%	66.65%	67.78%	70.42%	72.04%	76.26%	77.10%	79.57%	82.67%	84.49%
Debt to EBITDA	2.45	2.40	2.38	2.12	1.90	1.53	1.44	1.28	1.09	0.91
Net Debt to EBITDA	2.16	2.06	2.07	1.79	1.54	1.23	1.17	0.99	0.77	0.70
Long-Term Debt to EBITDA	2.45	2.40	2.38	2.12	1.90	1.53	1.44	1.28	1.09	0.91
Debt to NOPAT	4.27	4.11	4.14	3.67	3.24	2.61	2.43	2.13	1.81	1.50
Net Debt to NOPAT	3.76	3.52	3.60	3.09	2.62	2.09	1.97	1.66	1.27	1.14
Long-Term Debt to NOPAT	4.27	4.11	4.14	3.67	3.24	2.61	2.43	2.13	1.81	1.50
Altman Z-Score	4.64	4.89	5.24	5.82	5.75	6.84	7.52	8.17	9.88	9.18
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.59	2.40	2.88	2.94	3.16	2.12	2.61	2.83	2.98	1.99
Quick Ratio	1.39	1.41	1.64	1.68	1.91	1.28	1.61	1.65	1.77	1.07
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-371	-431	-395	-53	7.52	52	70	65	33	39
Operating Cash Flow to CapEx	277.58%	294.34%	360.49%	425.89%	560.76%	575.38%	483.18%	654.14%	560.80%	411.14%
Free Cash Flow to Firm to Interest Expense	-101.73	0.00	-70.98	0.00	0.00	0.00	12.97	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	11.43	0.00	6.26	0.00	0.00	0.00	6.19	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	7.31	0.00	4.52	0.00	0.00	0.00	4.91	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.67	0.67	0.58	0.57	0.57	0.58	0.58	0.59	0.60
Accounts Receivable Turnover	7.34	7.57	7.05	7.13	6.87	7.18	6.85	7.50	7.55	7.79
Inventory Turnover	5.85	6.28	5.69	4.91	4.93	5.41	5.27	5.09	5.26	5.14
Fixed Asset Turnover	3.77	3.70	3.66	3.59	3.50	3.37	3.38	3.43	3.45	3.42
Accounts Payable Turnover	11.65	11.66	13.25	10.65	10.27	11.00	10.94	11.12	12.84	11.20
Days Sales Outstanding (DSO)	49.73	48.22	51.77	51.16	53.16	50.82	53.25	48.64	48.33	46.87
Days Inventory Outstanding (DIO)	62.44	58.10	64.10	74.28	74.04	67.42	69.31	71.67	69.41	71.03
Days Payable Outstanding (DPO)	31.32	31.31	27.55	34.29	35.55	33.19	33.37	32.82	28.42	32.58
Cash Conversion Cycle (CCC)	80.85	75.01	88.31	91.16	91.65	85.05	89.19	87.50	89.32	85.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,319	1,364	1,376	1,363	1,346	1,343	1,339	1,334	1,350	1,340
Invested Capital Turnover	0.82	0.83	0.81	0.71	0.70	0.68	0.68	0.69	0.70	0.71
Increase / (Decrease) in Invested Capital	398	459	422	87	27	-21	-37	-29	3.89	-3.35
Enterprise Value (EV)	4,285	4,286	4,450	4,677	4,298	5,035	5,256	5,214	5,883	5,460
Market Capitalization	3,862	3,883	4,047	4,321	3,977	4,771	4,996	4,992	5,710	5,299
Book Value per Share	$27.89	$29.20	$30.26	$31.24	$31.80	$32.69	$33.27	$34.31	$36.29	$35.37
Tangible Book Value per Share	($2.50)	($1.39)	($0.32)	$0.93	$2.06	$2.60	$3.86	$5.13	$6.74	$6.30
Total Capital	1,376	1,408	1,436	1,430	1,423	1,382	1,399	1,398	1,424	1,361
Total Debt	480	470	463	423	398	328	321	286	247	211
Total Long-Term Debt	480	470	463	423	398	328	321	286	247	211
Net Debt	423	403	403	356	321	264	260	222	173	162
Capital Expenditures (CapEx)	15	14	9.66	8.22	8.30	12	6.91	6.88	9.15	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	170	129	159	155	156	101	140	143	143	107
Debt-free Net Working Capital (DFNWC)	226	196	219	222	233	166	200	207	217	156
Net Working Capital (NWC)	226	196	219	222	233	166	200	207	217	156
Net Nonoperating Expense (NNE)	2.06	6.25	4.12	3.48	5.69	4.06	3.80	3.56	3.16	2.23
Net Nonoperating Obligations (NNO)	423	426	403	356	321	289	260	222	173	190
Total Depreciation and Amortization (D&A)	14	14	14	13	14	14	14	13	11	11
Debt-free, Cash-free Net Working Capital to Revenue	18.37%	13.71%	16.79%	16.51%	16.87%	10.98%	15.07%	15.35%	15.16%	11.17%
Debt-free Net Working Capital to Revenue	24.49%	20.77%	23.16%	23.62%	25.17%	17.97%	21.56%	22.18%	22.98%	16.37%
Net Working Capital to Revenue	24.49%	20.77%	23.16%	23.62%	25.17%	17.97%	21.56%	22.18%	22.98%	16.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.79	$0.67	$0.71	$0.94	$0.91	$0.82	$0.90	$0.99	$1.05	$1.03
Adjusted Weighted Average Basic Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M
Adjusted Diluted Earnings per Share	$0.78	$0.66	$0.70	$0.93	$0.90	$0.82	$0.89	$0.98	$1.03	$1.03
Adjusted Weighted Average Diluted Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.14M	32.17M	32.23M	32.24M	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M
Normalized Net Operating Profit after Tax (NOPAT)	27	28	27	34	35	31	33	36	37	36
Normalized NOPAT Margin	11.18%	11.89%	11.54%	14.52%	15.12%	13.43%	13.68%	15.22%	15.42%	14.92%
Pre Tax Income Margin	12.73%	11.09%	12.52%	16.61%	15.86%	14.55%	15.38%	17.61%	18.29%	18.53%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.54	0.00	6.23	0.00	0.00	0.00	7.83	0.00	0.00	0.00
NOPAT to Interest Expense	7.50	0.00	4.82	0.00	0.00	0.00	6.07	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	5.42	0.00	4.50	0.00	0.00	0.00	6.55	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	3.38	0.00	3.09	0.00	0.00	0.00	4.79	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	19.03%	19.66%	23.07%	23.00%	22.15%	21.07%	22.26%	21.90%	21.04%	19.91%
Augmented Payout Ratio	66.52%	53.28%	27.79%	27.17%	26.21%	25.19%	27.33%	26.83%	25.83%	24.33%

Frequently Asked Questions About Balchem's Financials

When does Balchem's financial year end?

According to the most recent income statement we have on file, Balchem's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Balchem's net income changed over the last 9 years?

Balchem's net income appears to be on an upward trend, with a most recent value of $128.48 million in 2024, rising from $59.72 million in 2015. The previous period was $108.54 million in 2023.

What is Balchem's operating income?

Balchem's total operating income in 2024 was $182.91 million, based on the following breakdown:

Total Gross Profit: $336.21 million
Total Operating Expenses: $153.30 million

How has Balchem revenue changed over the last 9 years?

Over the last 9 years, Balchem's total revenue changed from $552.49 million in 2015 to $953.68 million in 2024, a change of 72.6%.

How much debt does Balchem have?

Balchem's total liabilities were at $425.46 million at the end of 2024, a 21.7% decrease from 2023, and a 2.3% increase since 2015.

How much cash does Balchem have?

In the past 9 years, Balchem's cash and equivalents has ranged from $38.64 million in 2016 to $103.24 million in 2021, and is currently $49.52 million as of their latest financial filing in 2024.

How has Balchem's book value per share changed over the last 9 years?

Over the last 9 years, Balchem's book value per share changed from 14.71 in 2015 to 35.37 in 2024, a change of 140.5%.

Remove Ads

Related Companies

This page (NASDAQ:BCPC) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Balchem (BCPC) Financials

Frequently Asked Questions About Balchem's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Balchem (BCPC) Financials

Annual Income Statements for Balchem

Quarterly Income Statements for Balchem

Annual Cash Flow Statements for Balchem

Quarterly Cash Flow Statements for Balchem

Annual Balance Sheets for Balchem

Quarterly Balance Sheets for Balchem

Annual Metrics and Ratios for Balchem

Quarterly Metrics and Ratios for Balchem

Frequently Asked Questions About Balchem's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools